P-糖蛋白——肿瘤细胞多药耐药的一种介质。 - Suppr

Suppr

超能文献

P-glycoprotein--a mediator of multidrug resistance in tumour cells.

作者信息

Germann U A

机构信息

Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts 02139-4211, USA.

出版信息

Eur J Cancer. 1996 Jun;32A(6):927-44. doi: 10.1016/0959-8049(96)00057-3.

DOI:10.1016/0959-8049(96)00057-3

PMID:8763334

Abstract

摘要

相似文献

P-glycoprotein--a mediator of multidrug resistance in tumour cells.

Eur J Cancer. 1996 Jun;32A(6):927-44. doi: 10.1016/0959-8049(96)00057-3.

Biology of the multidrug resistance-associated protein, MRP.

Eur J Cancer. 1996 Jun;32A(6):945-57. doi: 10.1016/0959-8049(96)00046-9.

Transporter molecules in multidrug resistance.

Cytotechnology. 1996;19(3):187-90. doi: 10.1007/BF00744211.

In vitro models of multiple drug resistance.

Cancer Treat Res. 1994;73:69-106. doi: 10.1007/978-1-4615-2632-2_5.

Cellular and biochemical characterization of VX-710 as a chemosensitizer: reversal of P-glycoprotein-mediated multidrug resistance in vitro.

Anticancer Drugs. 1997 Feb;8(2):125-40. doi: 10.1097/00001813-199702000-00004.

P-glycoprotein: its role in drug resistance.

Am J Med. 1995 Dec 29;99(6A):31S-34S. doi: 10.1016/s0002-9343(99)80283-6.

Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein.

Int J Oncol. 2000 Sep;17(3):579-86. doi: 10.3892/ijo.17.3.579.

Experimental modulation of MRP (multidrug resistance-associated protein)-mediated resistance.

Eur J Cancer. 1996 Jun;32A(6):1002-9. doi: 10.1016/0959-8049(96)00067-6.

The role of protein kinase C in multidrug resistance.

Cancer Treat Res. 1994;73:41-55. doi: 10.1007/978-1-4615-2632-2_3.

Kinetics of the P-glycoprotein, the multidrug transporter.

Exp Physiol. 1998 Mar;83(2):221-32. doi: 10.1113/expphysiol.1998.sp004106.

引用本文的文献

What Is Known about Breast Cancer in Young Women?

Cancers (Basel). 2023 Mar 22;15(6):1917. doi: 10.3390/cancers15061917.

Possible Use of miR-223-3p as a Prognostic Marker in Transarterial Chemoembolization Treatment of Hepatocellular Carcinoma Patients.

Asian Pac J Cancer Prev. 2022 Dec 1;23(12):4125-4135. doi: 10.31557/APJCP.2022.23.12.4125.

Curcumin: A Novel Way to Improve Quality of Life for Colorectal Cancer Patients?

Int J Mol Sci. 2022 Nov 14;23(22):14058. doi: 10.3390/ijms232214058.

Microfluidic chip enables single-cell measurement for multidrug resistance in triple-negative breast cancer cells.

Cancer Drug Resist. 2020 Mar 11;3(3):613-622. doi: 10.20517/cdr.2019.77. eCollection 2020.

5-arylalkynyl-2-benzoyl thiophene: a novel microtubule inhibitor exhibits antitumor activity without neurological toxicity.

Am J Cancer Res. 2022 Jan 15;12(1):229-246. eCollection 2022.

Monitoring the heterogeneity in single cell responses to drugs using electrochemical impedance and electrochemical noise.

Chem Sci. 2020 Dec 28;12(7):2558-2566. doi: 10.1039/d0sc05489e.

Chemotherapeutic drugs: Cell death- and resistance-related signaling pathways. Are they really as smart as the tumor cells?

Transl Oncol. 2021 May;14(5):101056. doi: 10.1016/j.tranon.2021.101056. Epub 2021 Mar 6.

Human ABCB1 with an ABCB11-like degenerate nucleotide binding site maintains transport activity by avoiding nucleotide occlusion.

PLoS Genet. 2020 Oct 8;16(10):e1009016. doi: 10.1371/journal.pgen.1009016. eCollection 2020 Oct.

Mucin-1 aptamer-armed superparamagnetic iron oxide nanoparticles for targeted delivery of doxorubicin to breast cancer cells.

Bioimpacts. 2018;8(2):117-127. doi: 10.15171/bi.2018.14. Epub 2018 May 5.

Induction of enhanced immunogenic cell death through ultrasound-controlled release of doxorubicin by liposome-microbubble complexes.

Oncoimmunology. 2018 Mar 26;7(7):e1446720. doi: 10.1080/2162402X.2018.1446720. eCollection 2018.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验